Shamburg News · 8-K filed Nov 16, 2026, 6:01 AM EST
DataMEDS AI Enters At-the-Market Sales Agreement with Dawson James Securities
MEDS · DataMeds AI, Inc.
- Material agreement
- Financing
- Materiality: medium
On November 16, 2026, DataMEDS AI, Inc. entered into an ATM sales agreement with Dawson James Securities, Inc. under which the company may sell shares of its common stock from time to time, up to a maximum amount set forth in the agreement. The company will pay the sales agent a fixed commission of 3.0% of aggregate gross proceeds. The shares are offered under a Form S-3 shelf registration statement (File No. 333-295078) and a prospectus supplement dated November 16, 2026.
Source: SEC EDGAR, Form 8-K, Items 1.01, 9.01, accession 0001493152-26-051924.
Written from the filing by Shamburg Markets. Figures are as reported by the company.